Tell CMS You Support Coverage for Obesity Medications

Have you been denied insurance coverage for a GLP-1?

Click the link to submit a Public Comment to CMS in Support of Expanding Coverage for Obesity Medications:

https://www.obesityaction.org/action-center/access-issues/CM SPublicCommentJanuary2025

In November, the Centers for Medicare and Medicaid Services (CMS) announced a Proposed Rule that would expand coverage for obesity medications under Medicare and Medicaid. There is a 60-day public comment period that allows individuals to submit feedback on the Proposed Rule.

Why YOU should submit a Public Comment:

• Public comments play a crucial role in shaping policy by making voices heard and contributing to meaningful change. OAC advocacy efforts have been instrumental in reaching this significant milestone.
• Your voice can help ensure access to obesity care for millions of Americans.
• Medicare and Medicaid coverage policy sets the standard for other insurers, both private and public.

Submit comments on the Proposed Rule by January 27th at 5 PM.

Hey Sarah!

You have great advice above. But there's a danger that these meds will be available at all under the current political climate.

I've been advocating for improved access to care for obesity treatments since 2013, there has always been bipartisan support for coverage of obesity medications. We keep moving forward with our stories and our ask for obesity to treated like any other chronic disease.

I think that bipartisan support is ending, I'm afraid.

Keep moving forward...I've always compared advocacy to managing chronic condition of obesity, can't stop doing what we're doing.

Expanding insurance coverage for GLP-1 drugs could make obesity treatment more accessible to more people. Hopefully this policy will be passed soon to benefit the community!